Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,362 | 210 | 87.3% |
| Travel and Lodging | $694.86 | 2 | 11.3% |
| Education | $85.52 | 2 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $732.42 | 41 | $0 (2024) |
| Intuitive Surgical, Inc. | $694.86 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $629.91 | 22 | $0 (2024) |
| Amgen Inc. | $625.75 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $430.69 | 17 | $0 (2024) |
| PFIZER INC. | $295.57 | 19 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $282.69 | 8 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $273.61 | 10 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $268.06 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $267.99 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,750 | 125 | Boehringer Ingelheim Pharmaceuticals, Inc. ($337.27) |
| 2023 | $2,059 | 69 | Janssen Pharmaceuticals, Inc ($429.37) |
| 2022 | $1,104 | 17 | Intuitive Surgical, Inc. ($694.86) |
| 2021 | $230.18 | 3 | Amgen Inc. ($115.80) |
All Payment Transactions
214 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: DIABETES | ||||||
| 12/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Cardiology | ||||||
| 12/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $3.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $1.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $30.70 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Heart Failure | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $3.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $33.71 | General |
| Category: Not Applicable | ||||||
| 10/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Cardiology | ||||||
| 10/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.55 | General |
| Category: Cardiovascular | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $39.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 565 | 700 | $99,890 | $34,932 |
| 2022 | 6 | 563 | 684 | $102,865 | $36,035 |
| 2021 | 6 | 604 | 874 | $132,602 | $48,714 |
| 2020 | 3 | 96 | 150 | $31,961 | $8,717 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 259 | $52,150 | $21,239 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 140 | $19,040 | $9,099 | 47.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 202 | 256 | $16,640 | $2,519 | 15.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 45 | 45 | $12,060 | $2,076 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 200 | 242 | $45,980 | $20,709 | 45.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 97 | $13,095 | $5,026 | 38.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 69 | 70 | $18,760 | $3,287 | 17.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 35 | $6,650 | $2,571 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 40 | $5,380 | $2,483 | 46.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 183 | 200 | $13,000 | $1,959 | 15.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 153 | 180 | $34,200 | $17,145 | 50.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 150 | 320 | $45,510 | $16,682 | 36.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 57 | 98 | $18,830 | $7,371 | 39.1% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 66 | 68 | $18,224 | $3,205 | 17.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 38 | $4,788 | $2,426 | 50.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 145 | 170 | $11,050 | $1,884 | 17.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 63 | 115 | $22,194 | $6,061 | 27.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 18 | $4,855 | $1,385 | 28.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 17 | 17 | $4,913 | $1,271 | 25.9% |
About Jared Marshall
Jared Marshall is a Medical healthcare provider based in Middletown, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2016. The National Provider Identifier (NPI) number assigned to this provider is 1265880918.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jared Marshall has received a total of $6,143 in payments from pharmaceutical and medical device companies, with $2,750 received in 2024. These payments were reported across 214 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,362).
As a Medicare-enrolled provider, Marshall has provided services to 1,828 Medicare beneficiaries, totaling 2,408 services with total Medicare billing of $128,398. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Medical
- Other Specialties Physician Assistant
- Location Middletown, CT
- Active Since 06/02/2016
- Last Updated 10/02/2018
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1265880918
Products in Payments
- Da Vinci Surgical System (Device) $694.86
- JARDIANCE (Drug) $670.40
- XARELTO (Drug) $629.91
- Repatha (Biological) $625.75
- Arcalyst (Drug) $273.61
- WATCHMAN Access System (Device) $267.41
- LEQVIO (Drug) $237.15
- VERQUVO (Drug) $233.37
- OPSUMIT (Drug) $224.98
- ELIQUIS (Drug) $203.48
- CAMZYOS (Drug) $201.25
- ENTRESTO (Drug) $193.54
- Inpefa (Drug) $171.90
- VYNDAQEL (Drug) $158.83
- FARXIGA (Drug) $151.38
- JOT DX (Device) $135.33
- MULTAQ (Drug) $133.70
- CardioMEMS HF System (Device) $102.84
- Wegovy (Drug) $76.80
- INJECTAFER (Drug) $74.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Middletown
Richard Whitehead, Pac, PAC
Medical — Payments: $9,182
Dennise Ramirez, Pa-C, PA-C
Medical — Payments: $2,095
Rebbecca Shea, Pa-C, PA-C
Medical — Payments: $1,929
Abigail Finkenauer, Pa-C, PA-C
Medical — Payments: $1,453
Jignesh Patel, Pa, PA
Medical — Payments: $897.20
Marissa Mutzek, Pa-C, PA-C
Medical — Payments: $709.10